Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors (Q35596016)

9 August 2017

title

Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors (English)

1 reference

9 August 2017

G H Koek

1

1 reference

9 August 2017

D Sifrim

2

1 reference

9 August 2017

T Lerut

3

1 reference

9 August 2017

J Janssens

4

1 reference

9 August 2017

J Tack

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

52

1 reference

9 August 2017

issue

10

1 reference

9 August 2017

page(s)

1397-1402

1 reference

Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Epidemiology and natural history of gastro-oesophageal reflux disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Mechanisms of gastroesophageal reflux in ambulant healthy human subjects

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773817

Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients

26 September 2018

1 reference

12 December 2020

The extent of duodenogastric reflux in gastro-oesophageal reflux disease

1 reference

12 December 2020

Analysis of ambulatory duodenogastroesophageal reflux monitoring

1 reference

12 December 2020

Composition of the postprandial refluxate in patients with gastroesophageal reflux disease

1 reference

12 December 2020

Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux

1 reference

12 December 2020

Mechanisms of gastroesophageal reflux in patients with reflux esophagitis

1 reference

12 December 2020

Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux

1 reference

12 December 2020

Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis

1 reference

12 December 2020

Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication

1 reference

12 December 2020

Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.52.10.1397

1 reference

9 August 2017

1 reference

9 August 2017

1 reference